How long does it take to lose weight on Wegovy?
How long does it take to lose weight on Wegovy? Some people notice changes within weeks, but steadier loss often takes months as the dose is titrated.
Key facts
- Semaglutide + B12 is $157/month (billed $157 every 4 weeks), charged only after a clinician approves it.
- Answer a few health questions online. A licensed clinician reviews them. If approved, it ships to your door.
- Adults 18 or older. A licensed clinician reviews your health history and decides whether treatment is appropriate for you. Availability depends on the state you live in.
If you are searching how long does it take to lose weight on Wegovy, the most accurate answer is that some people notice changes within weeks, but steadier change often takes months. Wegovy (semaglutide) is increased gradually, so your dose and tolerability can shape what you see early. This page summarizes what the FDA label and clinical trials show about typical timelines and why they vary. If you are exploring GLP-1 care through Vitals Vault, a licensed clinician reviews your history and helps set realistic expectations.
- Weight loss can start within weeks, but steadier change often takes months on Wegovy.
- The Wegovy label titrates dosing over 16 weeks, which affects early results.
- In STEP 1, weight loss continued building through 68 weeks with semaglutide 2.4 mg.
- GI side effects are common early and can slow dose increases.
- Seek urgent care for severe belly pain or allergic reaction symptoms.
Answer: the typical timeline
First several weeks
Some people notice reduced appetite and earlier fullness in the first weeks, which can lead to early weight change. In STEP 1, the published weight curve shows weight decreasing early and continuing over time. Early progress can be limited by lower starting doses and side effects during dose increases.
Around 4 months
The Wegovy prescribing information uses a stepwise dose increase over 16 weeks before the maintenance dose. Many people find results feel more consistent once they are on a stable, higher dose. If side effects require a slower schedule, the timeline can shift.
6 to 12 months and beyond
In STEP 1, adults without diabetes taking semaglutide 2.4 mg with lifestyle intervention had greater average weight loss than placebo at 68 weeks. That does not mean everyone responds the same way, but it supports that change is usually gradual rather than immediate. Your clinician can help interpret your trend over time.
What affects how fast results show
| Factor | Why it changes the timeline | What to discuss with a clinician |
|---|---|---|
| Dose escalation (titration) | The Wegovy label increases dose over 16 weeks, so early doses may have less effect. | Whether side effects require a slower increase or a pause. |
| Missed doses and restarts | Interruptions can reduce consistency, and the label gives specific missed dose and restart guidance. | How to handle missed doses safely and when to restart escalation. |
| Lifestyle program | In STEP 1, semaglutide was paired with reduced calorie diet and increased physical activity. | A realistic nutrition and activity plan you can sustain. |
| Side effects and tolerability | GI side effects are common and can affect eating and whether you can continue dose increases. | Ways to manage symptoms and when symptoms suggest dehydration. |
| Other conditions and medicines | Some conditions and medications affect weight. Semaglutide also delays gastric emptying, which can affect oral drug absorption. | Your full medication list and what monitoring you may need. |
Common side effects early on
The Wegovy label lists gastrointestinal side effects such as nausea, diarrhea, vomiting, constipation, and abdominal pain among the most common adverse reactions. These are often most noticeable during dose increases. If side effects limit eating or hydration, they can slow the pace of dose escalation and change your timeline.
Serious risks to know
Wegovy has a boxed warning about risk of thyroid C-cell tumors based on rodent studies and is contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2. The label also warns about acute pancreatitis, gallbladder disease, and acute kidney injury, especially with dehydration. If you have diabetes and use insulin or a sulfonylurea, the label warns about hypoglycemia risk.
What trials show over time
In STEP 1, semaglutide 2.4 mg plus lifestyle intervention produced greater average weight loss than placebo at 68 weeks. The publication shows weight loss building over many months. Your individual response can differ based on dose, adherence, and tolerability.
Plateaus can happen
Weight loss often slows after an initial period, even when a medication is still helping. This can reflect changes in calorie intake, activity, or your body adapting over time. A clinician can help decide whether your plan needs adjustment or whether other causes should be evaluated.
When to talk to a clinician
No change after escalation
If you have reached a stable, higher dose and still have little or no change, ask a clinician to review adherence, diet, activity, and other medical factors. They may also review whether another condition or medication is affecting weight. Do not change your dose on your own.
Persistent vomiting or diarrhea
Contact a clinician promptly if you cannot keep fluids down or you have signs of dehydration such as dizziness or reduced urination. The Wegovy label warns about acute kidney injury, often in the setting of dehydration. Seek urgent care if symptoms are severe.
Severe belly pain
Seek urgent evaluation for severe abdominal pain that does not go away, especially with vomiting. The label warns about acute pancreatitis and gallbladder disease. A clinician can determine whether you need testing or a medication change.
Neck lump or hoarseness
Report a lump in your neck, trouble swallowing, or persistent hoarseness. Wegovy carries a boxed warning about thyroid C-cell tumors and is not used in people with certain thyroid cancer histories. A clinician can assess symptoms and your risk factors.
Allergic reaction symptoms
Get emergency help for swelling of the face, lips, tongue, or throat, trouble breathing, or widespread rash. Hypersensitivity reactions are described in the prescribing information. Do not re-challenge unless a clinician tells you it is safe.
Practical tips to set expectations
Track trends, not days
Weekly averages and waist measurements can be more meaningful than daily scale changes.
Expect a gradual curve
Clinical trials show weight change builds over months, not overnight.
Tell your clinician early
If nausea or constipation is limiting eating or hydration, bring it up promptly.
Bring your medication list
Some medicines affect weight or appetite. A full list helps your clinician troubleshoot.
Use follow ups
Regular check ins help interpret progress and catch side effects early.
Frequently Asked Questions
How long does it take to lose weight on Wegovy?
Some people notice appetite changes and early weight change within the first several weeks, but steadier change often takes months as dosing is titrated. In STEP 1, weight loss continued to build through 68 weeks. Your dose, side effects, and lifestyle plan can shift the timeline.
When do you reach the full dose of Wegovy?
In the FDA prescribing information, Wegovy is titrated over 16 weeks before the maintenance dose. Some people may need a slower schedule if side effects occur. Your prescribing clinician decides the safest plan for you.
What if I am not losing weight after a few months on Wegovy?
If you have reached a stable, higher dose and are not seeing change, a clinician can review adherence, lifestyle factors, and other medical causes. They can also assess whether side effects are limiting dose escalation. Do not change dosing without medical guidance.
Do side effects happen before weight loss on Wegovy?
They can. The label lists gastrointestinal side effects like nausea, vomiting, diarrhea, constipation, and abdominal pain as common, especially during dose increases. If symptoms are severe or you cannot stay hydrated, contact a clinician promptly.
Is compounded semaglutide the same as Wegovy?
No. Wegovy is a brand product, while compounded semaglutide is prepared by a licensed pharmacy for an individual prescription and is not FDA-approved. If you are considering a compounded option through Vitals Vault, a licensed clinician reviews your history and decides whether it is appropriate.